Fulcrum Therapeutics Inc (FULC)
3.26
+0.05
(+1.56%)
USD |
NASDAQ |
Nov 04, 16:00
3.265
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Revenue (Quarterly): 80.00M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 80.00M |
March 31, 2024 | |
December 31, 2023 | 0.871M |
September 30, 2023 | 0.759M |
June 30, 2023 | 0.88M |
March 31, 2023 | 0.295M |
December 31, 2022 | 0.685M |
September 30, 2022 | 1.183M |
June 30, 2022 | 1.882M |
Date | Value |
---|---|
March 31, 2022 | 2.592M |
December 31, 2021 | 5.058M |
September 30, 2021 | 4.935M |
June 30, 2021 | 4.381M |
March 31, 2021 | 4.789M |
December 31, 2020 | 4.225M |
September 30, 2020 | 1.848M |
June 30, 2020 | 2.00M |
March 31, 2020 | 0.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.295M
Minimum
Mar 2023
80.00M
Maximum
Jun 2024
6.890M
Average
1.882M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
Bioventus Inc | 151.22M |
Arcturus Therapeutics Holdings Inc | 45.98M |
Entrada Therapeutics Inc | 94.69M |
Johnson & Johnson | 22.47B |
Insmed Inc | 93.42M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 55.41M |
Total Expenses (Quarterly) | 27.51M |
EPS Diluted (Quarterly) | 0.87 |
Enterprise Value | -70.35M |
Profit Margin (Quarterly) | 69.26% |
Earnings Yield | -10.74% |
Normalized Earnings Yield | -10.74 |